Biostage, Inc.
(Other OTC/NBB : HART)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.03%358.421.2%$822.65m
AMGNAmgen Inc.
-0.43%191.971.2%$549.69m
CELGCelgene Corporation
-0.13%85.671.2%$541.62m
GILDGilead Sciences, Inc.
0.69%77.650.9%$486.04m
SRPTSarepta Therapeutics, Inc.
-0.62%134.5116.6%$345.10m
VRTXVertex Pharmaceuticals Incorporated
-0.23%180.721.9%$321.35m
REGNRegeneron Pharmaceuticals, Inc.
0.12%366.422.6%$293.85m
ILMNIllumina, Inc.
0.81%309.773.5%$269.39m
BLUEBluebird Bio, Inc.
0.06%179.6515.7%$208.27m
NKTRNektar Therapeutics
1.89%48.795.6%$178.77m
ALXNAlexion Pharmaceuticals, Inc.
-0.37%135.152.0%$175.76m
FMIFoundation Medicine, Inc.
0.09%136.938.8%$160.93m
EXASExact Sciences Corporation
0.81%67.2825.4%$160.59m
EXELExelixis, Inc.
0.05%21.346.4%$135.83m
AAgilent Technologies, Inc.
2.05%64.281.5%$132.94m

Company Profile

Biostage, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded on May 3, 2012 and is headquartered in Holliston, MA.